Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity.

BACKGROUND IL-4, IL-5, and IL-13 are thought to be central to the allergic asthmatic response. Previous work supposed that the essential source of these cytokines was CD4(+) T(H)2 cells. However, more recent studies have suggested that other innate production of type 2 cytokines might be as important. OBJECTIVES Nuocytes are a novel population of IL-13-producing innate cells, which are critical for protective immunity in Nippostrongylus brasiliensis infection. Given this, we investigated the potential existence and functional importance of nuocytes in experimental allergic asthma. METHODS We generated Il4(+/eGFP)Il13(+/Tomato) dual-reporter mice to study cytokine-producing cells during allergic inflammation. We adoptively transferred innate IL-13-producing cells to investigate their role in airways hyperreactivity (AHR). RESULTS We show that allergen-induced nuocytes infiltrate the lung and are a major innate source of IL-13. CD4(+) T cells in the lung almost exclusively express only IL-13, whereas IL-4-producing T cells were restricted to the draining lymph nodes. Intranasal administration of IL-25 or IL-33 induced IL-13-producing nuocytes in the BAL fluid. Strikingly, adoptive transfer of wild-type nuocytes, but not Il13(-/-) nuocytes, into Il13(-/-) mice, which are normally resistant to IL-25-induced AHR, restored airways resistance and lung cell infiltration. CONCLUSIONS These findings identify nuocytes as a novel cell type in allergic lung inflammation and an innate source of IL-13 that can directly induce AHR in the absence of IL-13-producing CD4(+) T cells. These data highlight nuocytes as an important new consideration in the development of future allergic asthma therapy.

[1]  G. McKenzie,et al.  A distinct role for interleukin-13 in Th2-cell-mediated immune responses , 1998, Current Biology.

[2]  N. Copeland,et al.  A highly efficient recombineering-based method for generating conditional knockout mutations. , 2003, Genome research.

[3]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[4]  R. Locksley,et al.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [published erratum appears in J Exp Med 1997 May 5;185(9):1715] , 1996, The Journal of experimental medicine.

[5]  Philip Smith,et al.  IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. , 2002, Immunity.

[6]  K. Chung,et al.  Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. , 2007, The Journal of allergy and clinical immunology.

[7]  H. Keller Studies on chemotaxis. 3. Modification of Boyden's technique for the evaluation of chemotactic agents. , 1966, Immunology.

[8]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[9]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[10]  Dirk E. Smith,et al.  CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. , 2009, The Journal of allergy and clinical immunology.

[11]  Yong‐jun Liu,et al.  Interleukin 25 promotes the initiation of proallergic type 2 responses , 2007, The Journal of experimental medicine.

[12]  M. Leach,et al.  IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.

[13]  R. Locksley,et al.  Cytokine-secreting follicular T cells shape the antibody repertoire , 2009, Nature Immunology.

[14]  Andreas Radbruch,et al.  Regulation of expression of IL-4 alleles: analysis using a chimeric GFP/IL-4 gene. , 2001, Immunity.

[15]  P. Foster,et al.  Mechanism of interleukin‐25 (IL‐17E)‐induced pulmonary inflammation and airways hyper‐reactivity , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  A. McKenzie,et al.  Nuocytes and beyond: new insights into helminth expulsion. , 2011, Trends in parasitology.

[17]  D. Voehringer,et al.  Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system , 2006, The Journal of experimental medicine.

[18]  K. Rajewsky,et al.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.

[19]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[20]  D. Voehringer,et al.  Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. , 2004, Immunity.

[21]  R. Locksley,et al.  Requirements for Allergen-Induced Airway Hyperreactivity in T and B Cell-Deficient Mice , 1998, Molecular medicine.

[22]  A. McKenzie,et al.  Reciprocal expression of IL‐25 and IL‐17A is important for allergic airways hyperreactivity , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  Tsutomu Takeuchi,et al.  Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.

[24]  Ya-Jen Chang,et al.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.

[25]  W. Paul,et al.  Basophils Produce IL-4 and Accumulate in Tissues after Infection with a Th2-inducing Parasite , 2004, The Journal of experimental medicine.

[26]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[27]  Philip Smith,et al.  IL-13 Overexpression Predisposes to Anaphylaxis Following Antigen Sensitization1 , 2001, The Journal of Immunology.

[28]  T. Abe,et al.  IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.

[29]  W. Paul,et al.  How are TH2-type immune responses initiated and amplified? , 2010, Nature Reviews Immunology.

[30]  Niamh E Mangan,et al.  Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion , 2006, The Journal of experimental medicine.

[31]  P. Foster,et al.  Integrated Signals Between IL-13, IL-4, and IL-5 Regulate Airways Hyperreactivity , 2000, The Journal of Immunology.

[32]  David J. Erle,et al.  Systemically dispersed innate IL-13–expressing cells in type 2 immunity , 2010, Proceedings of the National Academy of Sciences.

[33]  D. Umetsu,et al.  Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity1 , 2001, The Journal of Immunology.